Biomedical nanomaterials: applications, toxicological concerns, and regulatory needs

Area of Science:

• Nanotechnology
• Biotechnology
• Materials Science

Background:

• Cutting-edge technologies like nanotechnology and biotechnology allow for the creation of novel nano-scale products with enhanced properties.
• Existing safety assessment processes, focused on bulk materials, are inadequate for nano-scale products.
• Despite recognized needs, policies for evaluating and controlling health risks of nano-enabled materials remain underdeveloped.

Purpose of the Study:

• To review progress in nanobiotechnology, focusing on practical advancements rather than future aspirations.
• To summarize persistent, unresolved challenges in nano-scale materials safety.
• To identify key barriers hindering the generation and integration of reliable data in the bio/nano-safety domain.

Main Methods:

• Literature review of current progress in nanobiotechnology.
• Analysis of existing safety assessment frameworks and their limitations for nanomaterials.
• Identification and discussion of barriers in bio/nano-safety data generation and integration.

Main Results:

• Significant advancements in nanobiotechnology offer new material possibilities.
• Long-standing issues concerning the safety of nanomaterials persist.
• Key barriers impede the development of robust bio/nano-safety data and policies.

Conclusions:

• The rapid development of nanobiotechnology necessitates updated safety assessment protocols.
• Addressing unresolved nano-safety issues and data integration barriers is crucial for responsible innovation.
• Particular focus is needed on nanostructured materials used in biomedical applications to ensure safety and efficacy.